CLINICAL_TRIALS
withdrawal
· 2013-10-08
Clinical Trial Update: Heart Safety Study of Ondansetron in Children Receiving Chemotherapy [Phase 4]
Summary
A Phase 4 trial assessing heart safety of ondansetron in children receiving chemotherapy has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oklahoma | Conditions: Malignant Childhood Neoplasm | Phase 4 | Status: WITHDRAWN